Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin A acid plus Rd in lenalidomide-resistant multiple myeloma
ChiCTR-OIN-16008243Phase 4Recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Apr 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tretinoin, lenalidomide and dexamethasone in multiple myeloma (MM), sponsored by Peking University People's Hospital. Primary endpoint: complete response rate. Started Apr 2016; status: recruiting.
02
Drugs
tretinoinlenalidomidedexamethasone
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on ChiCTR-OIN-16008243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OIN-16008243.